Statement in solidarity with PLHIV demanding access to HIV/AIDS medications
The Delhi Network of Positive People (DNP+), a network of people living with HIV (PLHIV), has been protesting for over a month outside the office of National AIDS Control Organisation (NACO) in Delhi. They are protesting against the ongoing shortage of Anti-Retroviral Therapy (ART) medicines. The shortage has been raging for more than five months […]
Prohibition and restriction of manufacture, sale and distribution of Fixed Dose Combinations (FDCs)
Health groups welcome price fixation of cardiac stents by NPPA
Health groups welcomed the notification by the National Pharmaceutical Pricing Authority (NPPA) of ceiling prices for coronary stents. The NPPA has notified a ceiling price for Drug Eluting Stents (DES) at Rs.29,600 and for Bare Metal Stents (BMS) at Rs.7,260 under the provisions of paragraph 19 of the Drugs Prices Control Order, 2013…read full statement […]
Jan Swasthya Abhiyan Expresses Concern and Shock at the Lifting of the ban order on 344 FDCs
The Jan Swasthya Abhiyan (JSA) expresses its deepest concern and shock at the verdict of the Delhi High Court, lifting the ban imposed on 344 Fixed Dose Combinations (FDCs) of drugs by the Government a few months back. This is a huge setback to efforts aimed at bringing a semblance of order into the absolute […]
Ban on FDCs: Public Health Must Prevail Over Corporate Profits
The Jan Swasthya Abhiyan compliments the Government for notifying a list of over 300 drug formulations, available as fixed‐dose combinations (FDCs) of two or more drugs, which are to be banned with immediate effect on the grounds of lack of “lack of therapeutic justification”. This is a long pending measure and needs to be followed […]